US case analysis: Myriad at the Supreme Court

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

US case analysis: Myriad at the Supreme Court

The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
more from across site and SHARED ros bottom lb

More from across our site

John Squires has had a range of in-house and private practice experience, most recently in the IP group at Dilworth Paxson
President Donald Trump’s attacks on Perkins Coie and Covington & Burling should not go unchallenged
The combined entity, which is expected to offer IP services across Australia and New Zealand, will be called Jones Maxwell Smith & Davis
The Iconix v Dream Pairs dispute, to be heard at the UK Supreme Court, concerns trademarks owned by sports brand Umbro and the issue of post-sale confusion
The European IP team from Simmons & Simmons discusses the current approaches to IP enforcement against look-a-like or copycat products
Ten firms have each received more than 11 nominations, while more than 20 in-house counsel are up for awards
Yanfeng Xiong discusses 6am wake ups, honing his basketball skills, and how he prioritises tasks
Saina Shamilov explains how she convinced the Federal Circuit to upend the US ITC’s domestic industry analysis
Christopher Kinkade and Naira Simmons reveal the distributed firm’s hiring hopes for 2025, a little more than a year after it was founded
A CJEU copyright decision on employees' rights and an update on an IP feud concerning foreign rights over 'Superman' were also among the top talking points
Gift this article